SCHEMBL3176144

SCHEMBL3176144

CC(=O)NCCNc1cc(NC(=O)CN2CCN(C(=O)OC(C)(C)C)CC2)nc(-c2ccccc2)n1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ ESR2 Q92731 1/20 0.46
▸ ACKR3 P25106 3/20 0.45
▸ ADORA3 P0DMS8 5/20 0.45
▸ ACHE P22303 1/20 0.43
▸ ADORA2B P29275 3/20 0.42
▸ ADORA1 P30542 2/20 0.42
▸ ADORA2A P29274 1/20 0.42
▸ CHRM2 P08172 1/20 0.42
▸ CHRM4 P08173 1/20 0.42
▸ CHRM1 P11229 1/20 0.42
▸ CHRM3 P20309 1/20 0.42
▸ CETP P11597 1/20 0.42
▸ P2RY12 Q9H244 2/20 0.41
▸ CKS1B P61024 1/20 0.40
▸ SKP1 P63208 1/20 0.40
▸ SKP2 Q13309 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3175828 0.90 P2RY12 (0.51) ALDH1A1MAPTADORA3P2RY12
SCHEMBL3163144 0.89 ADORA3 (0.46) ALDH1A1MAPTADORA3ADORA2BADORA1
SCHEMBL3171920 0.86 ADORA1 (0.47) ALDH1A1ADORA3ADORA2BADORA1ADORA2A
SCHEMBL3163125 0.85 NPC1 (0.47) ALDH1A1MAPTADORA3ADORA2BADORA1
SCHEMBL3164709 0.85 NPC1 (0.47) ALDH1A1MAPTADORA3ADORA2BADORA1
SCHEMBL3260230 0.85 ADORA3 (0.46) ALDH1A1ADORA3ADORA2BADORA1ADORA2A
SCHEMBL3163746 0.85 ALDH1A1 (0.50) ALDH1A1MAPTADORA3ADORA2BADORA1
SCHEMBL3162425 0.85 EGFR (0.53) ALDH1A1MAPT
SCHEMBL3169937 0.85 ALDH1A1 (0.48) ALDH1A1ADORA3ADORA2BADORA1ADORA2A
SCHEMBL3165639 0.84 ADORA3 (0.43) ALDH1A1ADORA3ADORA2BADORA1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback